Man Group’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.65M | Sell |
392,117
-148,747
| -28% | -$573K | ﹤0.01% | 1646 |
|
|
2026
Q1 | $1.9M | Buy |
540,864
+493,205
| +1,035% | +$2.02M | ﹤0.01% | 1596 |
|
|
2025
Q4 | $161K | Buy |
+47,659
| New | +$124K | ﹤0.01% | 2158 |
|
|
2025
Q3 | – | Sell |
-234,257
| Closed | -$168K | – | 2338 |
|
|
2025
Q2 | $168K | Sell |
234,257
-99,461
| -30% | -$78.1K | ﹤0.01% | 2095 |
|
|
2025
Q1 | $491K | Sell |
333,718
-21,106
| -6% | -$50.3K | ﹤0.01% | 1801 |
|
|
2024
Q4 | $1.57M | Sell |
354,824
-539,902
| -60% | -$2.19M | ﹤0.01% | 1383 |
|
|
2024
Q3 | $3.69M | Sell |
894,726
-2,089,725
| -70% | -$11.2M | 0.01% | 1128 |
|
|
2024
Q2 | $19.5M | Sell |
2,984,451
-862
| -0% | -$6.1K | 0.05% | 448 |
|
|
2024
Q1 | $26M | Buy |
2,985,313
+1,559,924
| +109% | +$18.9M | 0.07% | 338 |
|
|
2023
Q4 | $16.3M | Buy |
+1,425,389
| New | +$14.1M | 0.05% | 471 |
|
|
2023
Q3 | – | Sell |
-2,976,050
| Closed | -$29.2M | – | 296 |
|
|
2023
Q2 | $31.7M | Buy |
+2,976,050
| New | +$32M | 0.1% | 252 |
|
|
2023
Q1 | – | Sell |
-1,384,470
| Closed | -$15.5M | – | 436 |
|
|
2022
Q4 | $17.2M | Buy |
1,384,470
+546,193
| +65% | +$6.2M | 0.06% | 386 |
|
|
2022
Q3 | $8.68M | Buy |
+838,277
| New | +$9.5M | 0.04% | 519 |
|
|
2022
Q2 | – | Sell |
-216,309
| Closed | -$2.55M | – | 1076 |
|
|
2022
Q1 | $2.72M | Sell |
216,309
-66,685
| -24% | -$764K | 0.01% | 1120 |
|
|
2021
Q4 | $3.3M | Sell |
282,994
-16,489
| -6% | -$202K | 0.01% | 1023 |
|
|
2021
Q3 | $3.91M | Sell |
299,483
-95,551
| -24% | -$1.23M | 0.01% | 941 |
|
|
2021
Q2 | $5.08M | Buy |
395,034
+208,808
| +112% | +$2.39M | 0.02% | 877 |
|
|
2021
Q1 | $2.08M | Sell |
186,226
-1,531,745
| -89% | -$16.2M | 0.01% | 1091 |
|
|
2020
Q4 | $19.6M | Sell |
1,717,971
-307,697
| -15% | -$3.37M | 0.09% | 228 |
|
|
2020
Q3 | $18.2M | Buy |
2,025,668
+1,154,168
| +132% | +$11.5M | 0.07% | 293 |
|
|
2020
Q2 | $8.99M | Buy |
871,500
+79,637
| +10% | +$815K | 0.05% | 394 |
|
|
2020
Q1 | $7.99M | Buy |
791,863
+621,395
| +365% | +$7.3M | 0.05% | 355 |
|
|
2019
Q4 | $2.27M | Buy |
+170,468
| New | +$1.88M | 0.01% | 1295 |
|
|
2019
Q2 | – | Sell |
-107,015
| Closed | -$1.21M | – | 1940 |
|
|
2019
Q1 | $1.21M | Buy |
107,015
+64,063
| +149% | +$715K | ﹤0.01% | 1524 |
|
|
2018
Q4 | $373K | Sell |
42,952
-109,285
| -72% | -$1.25M | ﹤0.01% | 1684 |
|
|
2018
Q3 | $2.35M | Buy |
+152,237
| New | +$2.41M | 0.01% | 1357 |
|
Other funds holding IRWD
AC
SCM
Man Group's IRWD Position: Q2 2026 in Review
Man Group reduced its Ironwood Pharmaceuticals (IRWD) stake by 28% in Q2 2026, selling an estimated $573K and leaving 392,117 shares worth $1.65M. The position accounts for ﹤0.01% of the portfolio, ranked #1646.
Man Group first reported a position in IRWD in Q3 2018 and has held it in 26 quarters since. The position peaked at $31.7M in Q2 2023. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.
- Man Group held 392,117 shares of Ironwood Pharmaceuticals worth $1.65M as of Q2 2026.
- Man Group sold 148,747 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $573K.
- Ironwood Pharmaceuticals made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #1646 holding.
- Man Group first reported a position in Ironwood Pharmaceuticals in Q3 2018 and has held it in 26 quarters since.
- Man Group's Ironwood Pharmaceuticals position peaked at $31.7M in Q2 2023.
- 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.
Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.